Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis

Eur J Vasc Endovasc Surg. 2008 Jan;35(1):19-30. doi: 10.1016/j.ejvs.2007.07.022. Epub 2007 Oct 24.

Abstract

Background: Candidate gene analysis has been frequently used in attempts to understand the pathological processes involved in many aspects of AAA disease.

Methods: This paper sets out a systems approach to reviewing AAA candidate gene analysis studies, whilst, explaining the key principles and design limitations of this universally applied technique. In addition we have performed a meta-analysis of six gene polymorphisms (ACE I/D, MTHFR+677C>T, MMP9-1562C>T, Il-1Beta/3953C>T, eNOS 4a/4b & TIMP1/+434C>T) reported in multiple case control studies.

Results and conclusions: Three of these polymorphisms were associated with a significant risk of AAA, ACE RR 1.33 [95% CI 1.20-1.48], MTHFR RR 1.14 [1.08-1.21] and MMP9 RR 1.09 [1.01-1.18]. These differences have been previously reported as equivocal, within a context of contradictory studies and as such this meta-analysis provides new evidence for their involvement in AAA disease. The plausibility of these findings is discussed within the context of a systems approach to the pathology of AAA disease.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aortic Aneurysm, Abdominal / enzymology
  • Aortic Aneurysm, Abdominal / genetics*
  • Disease Progression
  • Gene Expression Regulation, Enzymologic
  • Genetic Predisposition to Disease
  • Humans
  • Interleukin-1beta / genetics
  • Matrix Metalloproteinase 9 / genetics*
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Nitric Oxide Synthase Type III / genetics
  • Peptidyl-Dipeptidase A / genetics*
  • Polymorphism, Single Nucleotide*
  • Risk Assessment
  • Risk Factors
  • Tissue Inhibitor of Metalloproteinase-1 / genetics

Substances

  • Interleukin-1beta
  • Tissue Inhibitor of Metalloproteinase-1
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Methylenetetrahydrofolate Reductase (NADPH2)
  • Peptidyl-Dipeptidase A
  • Matrix Metalloproteinase 9